![A Negative Antinuclear Antibody Does Not Indicate Autoantibody Negativity in Myositis: Role of Anticytoplasmic Antibody as a Screening Test for Antisynthetase Syndrome | The Journal of Rheumatology A Negative Antinuclear Antibody Does Not Indicate Autoantibody Negativity in Myositis: Role of Anticytoplasmic Antibody as a Screening Test for Antisynthetase Syndrome | The Journal of Rheumatology](https://www.jrheum.org/content/jrheum/44/2/223/F1.large.jpg)
A Negative Antinuclear Antibody Does Not Indicate Autoantibody Negativity in Myositis: Role of Anticytoplasmic Antibody as a Screening Test for Antisynthetase Syndrome | The Journal of Rheumatology
![Serum-circulating His-tRNA synthetase inhibits organ-targeted immune responses | Cellular & Molecular Immunology Serum-circulating His-tRNA synthetase inhibits organ-targeted immune responses | Cellular & Molecular Immunology](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41423-019-0331-0/MediaObjects/41423_2019_331_Fig1_HTML.png)
Serum-circulating His-tRNA synthetase inhibits organ-targeted immune responses | Cellular & Molecular Immunology
![Rituximab in the Treatment of Jo1 Antibody–associated Antisynthetase Syndrome: Anti-Ro52 Positivity as a Marker for Severity and Treatment Response | The Journal of Rheumatology Rituximab in the Treatment of Jo1 Antibody–associated Antisynthetase Syndrome: Anti-Ro52 Positivity as a Marker for Severity and Treatment Response | The Journal of Rheumatology](https://www.jrheum.org/content/jrheum/43/8/1566/F1.large.jpg)
Rituximab in the Treatment of Jo1 Antibody–associated Antisynthetase Syndrome: Anti-Ro52 Positivity as a Marker for Severity and Treatment Response | The Journal of Rheumatology
![PDF] Anti-Jo-1 antibody-positive patients show a characteristic necrotizing perifascicular myositis. | Semantic Scholar PDF] Anti-Jo-1 antibody-positive patients show a characteristic necrotizing perifascicular myositis. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/ede2d8bf75a7089ff6ff92e02c01a444f0882680/4-Table1-1.png)
PDF] Anti-Jo-1 antibody-positive patients show a characteristic necrotizing perifascicular myositis. | Semantic Scholar
![Patients with anti-Jo1 antibodies display a characteristic IgG Fc-glycan profile which is further enhanced in anti-Jo1 autoantibodies | Scientific Reports Patients with anti-Jo1 antibodies display a characteristic IgG Fc-glycan profile which is further enhanced in anti-Jo1 autoantibodies | Scientific Reports](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-018-36395-z/MediaObjects/41598_2018_36395_Fig1_HTML.png)
Patients with anti-Jo1 antibodies display a characteristic IgG Fc-glycan profile which is further enhanced in anti-Jo1 autoantibodies | Scientific Reports
![Identifying Jo-1-Specific B Cells in the Primary Immune Repertoire in Idiopathic Inflammatory Myopathies - ACR Meeting Abstracts Identifying Jo-1-Specific B Cells in the Primary Immune Repertoire in Idiopathic Inflammatory Myopathies - ACR Meeting Abstracts](https://acrabstracts.org/wp-content/uploads/2019/08/GTUOHVCE-699756-1-ANY.png)
Identifying Jo-1-Specific B Cells in the Primary Immune Repertoire in Idiopathic Inflammatory Myopathies - ACR Meeting Abstracts
![Patients with anti-Jo1 antibodies display a characteristic IgG Fc-glycan profile which is further enhanced in anti-Jo1 autoantibodies | Scientific Reports Patients with anti-Jo1 antibodies display a characteristic IgG Fc-glycan profile which is further enhanced in anti-Jo1 autoantibodies | Scientific Reports](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41598-018-36395-z/MediaObjects/41598_2018_36395_Fig3_HTML.png)
Patients with anti-Jo1 antibodies display a characteristic IgG Fc-glycan profile which is further enhanced in anti-Jo1 autoantibodies | Scientific Reports
![Myopathy with anti-Jo-1 antibodies: pathology in perimysium and neighbouring muscle fibres | Journal of Neurology, Neurosurgery & Psychiatry Myopathy with anti-Jo-1 antibodies: pathology in perimysium and neighbouring muscle fibres | Journal of Neurology, Neurosurgery & Psychiatry](https://jnnp.bmj.com/content/jnnp/68/4/472/F3.large.jpg?width=800&height=600&carousel=1)
Myopathy with anti-Jo-1 antibodies: pathology in perimysium and neighbouring muscle fibres | Journal of Neurology, Neurosurgery & Psychiatry
![Myopathy with anti-Jo-1 antibodies: pathology in perimysium and neighbouring muscle fibres | Journal of Neurology, Neurosurgery & Psychiatry Myopathy with anti-Jo-1 antibodies: pathology in perimysium and neighbouring muscle fibres | Journal of Neurology, Neurosurgery & Psychiatry](https://jnnp.bmj.com/content/jnnp/68/4/472/F4.large.jpg)
Myopathy with anti-Jo-1 antibodies: pathology in perimysium and neighbouring muscle fibres | Journal of Neurology, Neurosurgery & Psychiatry
![A unique autoantibody pattern of positive anti-Jo-1, anti-U1RNP, and antiproteasome antibodies in autoimmune myositis as a diagnostic challenge | Annals of the Rheumatic Diseases A unique autoantibody pattern of positive anti-Jo-1, anti-U1RNP, and antiproteasome antibodies in autoimmune myositis as a diagnostic challenge | Annals of the Rheumatic Diseases](https://ard.bmj.com/content/annrheumdis/62/4/370/F1.large.jpg)
A unique autoantibody pattern of positive anti-Jo-1, anti-U1RNP, and antiproteasome antibodies in autoimmune myositis as a diagnostic challenge | Annals of the Rheumatic Diseases
![Myopathy with anti-Jo-1 antibodies: pathology in perimysium and neighbouring muscle fibres | Journal of Neurology, Neurosurgery & Psychiatry Myopathy with anti-Jo-1 antibodies: pathology in perimysium and neighbouring muscle fibres | Journal of Neurology, Neurosurgery & Psychiatry](https://jnnp.bmj.com/content/jnnp/68/4/472/F1.large.jpg?width=800&height=600&carousel=1)